OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO) today announced that Katherine Richardson, PhD, Vice President of Research & Development, will deliver a keynote address on June 11, 2015 at the GTBio Cancer Markers & Liquid Biopsies Conference. In her talk, Dr. Richardson will highlight how Transgenomic’s breakthrough Multiplexed ICE COLD-PCR™ (MX-ICP) technology uniquely enables use of liquid biopsies and broader adoption of precision and personalized medicine.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
